Just Other Articles

The Leader's Fallacy lives! We subscribe to the Fallacy when we believe our enthusiasm over a particular leadership challenge is automatically reciprocated by the people we lead

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

.

If ignorance is bliss then leaders going around blithely adhering to the Leader's Fallacy have cornered the market on happiness.

The truth is, it's more realistic to believe

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

in INVERSE RECIPROCITY: i.e., whatever motivates you, "DE-motivates" the people.

That's especially so for leaders who are trying to motivate people to meet extraordinary challe

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ges.

You'll never know how good you are as a leader unless you are motivating others to be better than they think they are. In that endeavor, you'll inevitably get at least som

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

of the people angry.

Most people are settled into a comfortable status quo and resist and resent being challenged to break out.

But if you aim to get great results, people no

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

only have to be pushed but more importantly, they must be challenged to push themselves.

So, if you're not getting some people angry with you over the pushing, you're doing so

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

mething wrong as a leader, you're not challenging people enough.

This doesn't mean you can't or shouldn't have the people share in your enthusiasms. You must. That sharing is

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

called CRITICAL CONFLUENCE, the joining of your enthusiasms and theirs so they are as enthusiastic as you about meeting the challenges you face. Until a critical confluence happ

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ns, you can't get great results consistently.

The Leader's Fallacy is an obstacle to the critical confluence. Don't think the Critical Confluence will happen automatically. Kn

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

w instead that you must work hard to achieve it.

After all, you yourself must be motivated about those challenges. If you're not motivated, you shouldn't be leading. But your

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

motivation is irrelevant simply because it's a given.

Here's what's relevant: Can you transfer your motivation to the people so they are as motivated as you are? And can you tr

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

anslate their motivation into action that achieves results?

Everyone has major needs that shape their thinking and their actions day in and day out. If you want those people t

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

take ardent action for you, you must provide solutions to the problems of those needs so the action you have them take brings them closer to realizing those solutions.

By the

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ay, the critical confluence is not "win/win". It's much deeper and richer. Unlike "win/win", the critical confluence is an on-going relationship process from which flow mutual

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

y beneficial expectations and solutions.

Here are three steps you can take to help make a critical confluence happen.

(1) Understand their needs.

(2) Turn their needs into pr

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

blems.

(3) Have their commitment to your cause be a solution to their problems.

To get the best out of people, we must embrace the best in them. Whenever you need to lead peo

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ple to tackle important challenges, recall the Leader's Fallacy. Know that their commitment to your cause doesn't come automatically. You have to earn it by embracing the best

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

of who they are. When you take the trouble to build a critical convergence, you'll see a significant jump in the results you have others achieve.

2005 © The Filson Leadership

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

appears with the included copyright, resource box and live web site link. Email notice of intent to publish is appreciated but not required: mail to: brent@actionleadership.co

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/24102/justotherarticles-In-Leadership-The-Critical-Convergence-Drives-Great-Results.html">In Leadership, The Critical Convergence Drives Great Results</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/24102/justotherarticles-In-Leadership-The-Critical-Convergence-Drives-Great-Results.html]In Leadership, The Critical Convergence Drives Great Results[/url]

Everything that we do has a purpose. We do things to please people, to make them recognize us and keep a good bonding relationship among them. Just like advertising materials they are purposively used in order to make a certain business recognizable in the market and meet a certain goal which is to earn more sales and profits.

Does your organization embrace change? If not, would you like to learn how to lead transitions more effectively? Would you like to reduce resistance and sabotage to your needed changes? These tips can help you to reduce your stress.

When you're new to the responsibility of buying industrial furniture, it's difficult to quickly get a grasp of the range of products available, and even harder to determine which products will work best for your needs.

Tags

Links

Just Other Articles - In Leadership, The Critical Convergence Drives Great Results

Related Articles: